Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Cubist Pharmaceuticals for $236,300.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI056858-01 | Phase I | 236,300 | ||||||||
A SBIR Phase II contract was awarded to Cubist Pharmaceuticals for $900,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM068173-02 | Phase II | 900,000 | ||||||||
A SBIR Phase I contract was awarded to Cubist Pharmaceuticals for $258,205.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM068173-01 | Phase I | 258,205 | ||||||||
A SBIR Phase I contract was awarded to Cubist Pharmaceuticals for $258,814.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI052909-01 | Phase I | 258,814 | ||||||||
A SBIR Phase II contract was awarded to Cubist Pharmaceuticals for $485,720.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 485,720 | |||||||||
A SBIR Phase I contract was awarded to Cubist Pharmaceuticals for $208,500.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 208,500 | |||||||||
A SBIR Phase I contract was awarded to Cubist Pharmaceuticals from the U.S. Department of Health & Human Services. | SBIR | Phase I | 0 |